Applications published 13 December 2006

Inhalent formulation containing sulfoalkyl ether gamma-cyclodextryn and corticosteroid
Cydex 1729724*

Pharmaceutical ocular preparations suitable for the treatment of the ocular surface and related disorders/diseases
Institute of Ophthamology, University College London; Moorfields Eye Hospital NHS Foundation Trust 1729725*

Application of a bioactive agent to a delivery substrate
Hewlett-Packard 1729726*

Improved formulations of 6-mercaptopurine
Teva Pharmaceutical Industries 1729727*

Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
Chiesi Farmaceutici 1729728*

Pharmaceutical compsns
Novartis 1729729*

Tamper resistant dosage form comprising an adsorbent and an adverse agent
Euro-Celtique 1729730*

Particulates
Euro-Celtique 1729731*

Anionic hydrogel matrices with pH dependent modified release as drug carriers
Sigma-Tau Industrie Farmaceutiche Riunite 1729732*

Hydrogel microspheres with improved release profile
OctoPlus Technologies 1729733*

Spray dried pharmaceutical compsns
SmithKline Beecham 1729734*

Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
Teva Pharmaceutical Industries 1729735*

Galenic formulations of organic compounds
Novartis 1729736*

Disintegrating tablets comprising licarbazepine
Novartis 1729737*

Polymeric compsns and dosage forms containing the same
McNeil-PPC 1729738*

Process for preparing a solid pharmaceutical compsn
KRKA 1729739*

Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABA B receptor agonist
Impax Laboratories 1729740*

Polymeric drug delivery system for hydrophobic drugs
Spherics 1729741*

Enteric coatings for orally ingestible substrates
BPSI Holdings 1729742*

Pharmaceutical compsns comprising a proton pump inhibitor and a prokinetic agent
Panacea Biotec 1729743*

Pharmaceutical formulations
SmithKline Beecham 1729744*

Method for producing CS particles and microcapsules using porous templates, CS particles and microcapsules, and the use thereof
Capsulation Nanoscience 1729745*

Means for transdermal administration of nicotine
Pfizer Health 1729746*

Thiol reactive agents as a therapeutic modality
Duke University 1729747*

Microemulsion preconcentrate comprising a renin inhibitor
Novartis 1729748*

Use of renin inhibitors in therapy
Novartis 1729749*

Method for inhibiting tumour formulation and growth
The Ludwig Institute for Cancer Research 1729750*

Use of an NK3 antagonist for the treatment of bipolar disorders
SmithKline Beecham 1729751*

Method for treating aortic stenosis with non-antibacterial tetracycline formulations
Collagenex Pharmaceuticals 1729752*

Use of an NMSDA receptor antagonist in the treatment of tinnitus induced by cochlear excitotoxicity
Auris Medical; Institut National de la Sante et de la Recherche Medicale (INSERM) 1729753*

Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
Eli Lilly 1729754*

Methods of treatment of amyloidosis using aspartyl-protease inhibitors
Elan Pharmaceuticals 1729755*

Novel pharmaceutical compsns
Karo Bio 1729756*

Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
Trustees of Tufts College 1729757*

Andrographoline and analogues as inhibitors of TNF-alpha and IL-1 beta expression
Hutchison Medipharma Enterprises 1729758*

Salvinorin derivatives and uses thereof
The McLean Hospital Corp 1729759*

Use of beta-lapachone for the treatment of lung cancer
Arqule 1729760*

Cadasil treatment with cholinesterase inhibitors
Eisai 1729761*

Combination therapy for weight management
Neurogen 1729762*

Novel bicyclic compounds as modulators of androgen receptor function
Bristol-Myers Squibb 1729763*

Novel bicyclic compounds as modulators of androgen receptor function and method
Bristol-Myers Squibb 1729763*

Methods of using and compsns comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
Celgene 1729764*

Use of a pyrazole derivative for producing medicaments that are useful in preventing and treating chronic bronchitis and chronic obstructive bronchopneumopathy
Sanofi-Aventis 1729765*

Pharmaceutical formulation
LEK Pharmaceuticals 1729766*

Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity
Les Laboratoires Servier; Centre National de la Recherche Scientifique (CNRS) 1729767*

Immune response modifier formulations and methods
3M Innovative Properties 1729768*

Compsns with reduced hepatotoxicity
Winston Laboratories1 1729769*

SNS-595 and methods for using the same
Sunesis Pharmaceuticals 1729770*

Pyridyl derivatives and their use as MGLU5 receptor antagonists
Eli Lilly 1729771*

Heteroaryl piperidine glycine transporter inhibitors
Merck; Merck Sharpe & Dohme 1729772*

8-hydroxy-5-[(-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl] amino][ethyl-2-(1H)-quinoline monohydrochloride in crystalline form and process for its preparation
Chiesi Farmaceutici 1729773*

Pyrrolidine compounds
National Health Research Institutes 1729774*

Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
Avecia Pharmaceuticals 1729775*

Pyyrole derivatives a gonadotropin releasing hormone (GNRH) antagonists
AstraZeneca 1729776*

Pharmaceutical compsn comprising a salt of mirtazapine
NV Organon 1729777*

Pharmaceutical preparation containing drospirenone for application to the skin
Schering 1729778*

Coating method
Ferring 1729779*

Methods for protein production
Centocor1 1729780*

A method of inhibiting cancer cell proliferation or increasing cancer cell apoptosis
Karaolis, David 1729781*

Treatment and prophylaxis of septic shock
Polytechnic University 1729782*

Eye drops of filtered clayey water for treating glaucoma
Neumann, Armand 1729785*

Administration of cisplatin by inhalation
Transave 1729786*

Method of proliferating precursor cells
Meakin, Susan Oriole 1729787*

Restenosis therapy using mesenchymal stem cells
Boston Scientific 1729788*

Amphipathic glycopeptides
Polt, Robin; The Arizona Board of Regents on behalf of the University of Arizona 1729790*

Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor
Chiron 1729791*

Y4 selective receptor agonists for therapeutic interventions
7TM Pharma 1729792*

ALK7 and myostatin inhibitors and uses thereof
Acceleron Pharma 1729793*

A pharmaceutical compsn comprising an active principle and sulphobetaine
LEK Pharmaceuticals 1729794*